These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14579780)

  • 1. Chemokine receptor antagonists from discovery to the clinic.
    Horuk R
    Ernst Schering Res Found Workshop; 2004; (44):169-90. PubMed ID: 14579780
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemokines.
    Horuk R
    ScientificWorldJournal; 2007 Feb; 7():224-32. PubMed ID: 17334613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines as molecular targets for therapeutic intervention.
    Howard OM; Oppenheim JJ; Wang JM
    J Clin Immunol; 1999 Sep; 19(5):280-92. PubMed ID: 10535604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemokines--perspectives for using agents that block their action in therapy].
    Waśniowska K
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():37-46. PubMed ID: 15069373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial chemokines in autoimmune disease.
    Christopherson KW; Hromas RA
    Curr Pharm Des; 2004; 10(2):145-54. PubMed ID: 14754394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ; Proudfoot AE
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor antagonists: overcoming developmental hurdles.
    Horuk R
    Nat Rev Drug Discov; 2009 Jan; 8(1):23-33. PubMed ID: 19079127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and atherosclerosis.
    Sheikine Y; Hansson GK
    Ann Med; 2004; 36(2):98-118. PubMed ID: 15119830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical potential of chemokine receptor antagonists.
    Ribeiro S; Horuk R
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for chemokine antagonists as therapeutics.
    Proudfoot AE; Power CA; Rommel C; Wells TN
    Semin Immunol; 2003 Feb; 15(1):57-65. PubMed ID: 12495641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines and angiogenesis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questions about chemokine and chemokine receptor antagonism in renal inflammation.
    Anders HJ; Sayyed SA; Vielhauer V
    Nephron Exp Nephrol; 2010; 114(2):e33-8. PubMed ID: 19887844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting chemokines: Pathogens can, why can't we?
    Proudfoot AE; Bonvin P; Power CA
    Cytokine; 2015 Aug; 74(2):259-67. PubMed ID: 25753743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines and their receptors in infectious disease.
    McDermott DH; Murphy PM
    Springer Semin Immunopathol; 2000; 22(4):393-415. PubMed ID: 11155443
    [No Abstract]   [Full Text] [Related]  

  • 17. The progress of chemokines and chemokine receptors in autism spectrum disorders.
    Ye J; Wang H; Cui L; Chu S; Chen N
    Brain Res Bull; 2021 Sep; 174():268-280. PubMed ID: 34077795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP; Zwillich SH; Clucas AT; Brown MF
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine signaling defines novel targets for therapeutic intervention.
    Rodríguez-Frade JM; Martínez-A C; Mellado M
    Mini Rev Med Chem; 2005 Sep; 5(9):781-9. PubMed ID: 16178721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.